{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/PRTA/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T16:14:40.167Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":10264,"canonical_name":"PROTHENA CORP PUBLIC LTD CO","cik":"0001559053","uei":null,"lei":null,"duns":null,"ticker":"PRTA"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":50},"count":50,"timeline":[{"ts":"2026-10-02","kind":"sec.filing","form_type":"8-K","title":"8-K — PROTHENA CORP PUBLIC LTD CO — 2026-10-02","url_slug":"/sec/cik-0001559053/8-k/0001559053-26-000024","accession_number":"0001559053-26-000024","importance":35},{"ts":"2026-08-19","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — PROTHENA CORP PUBLIC LTD CO — 2026-08-19","url_slug":"/sec/cik-0001559053/schedule-13g-a/0002011420-26-000007","accession_number":"0002011420-26-000007","importance":30},{"ts":"2026-08-18","kind":"sec.filing","form_type":"3","title":"3 — PROTHENA CORP PUBLIC LTD CO — 2026-08-18","url_slug":"/sec/cik-0001559053/3/0002011420-26-000005","accession_number":"0002011420-26-000005","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — PROTHENA CORP PUBLIC LTD CO — 2026-08-14","url_slug":"/sec/cik-0001559053/schedule-13g-a/0002011420-26-000004","accession_number":"0002011420-26-000004","importance":30},{"ts":"2026-08-11","kind":"sec.filing","form_type":"3","title":"3 — PROTHENA CORP PUBLIC LTD CO — 2026-08-11","url_slug":"/sec/cik-0001559053/3/0002011420-26-000001","accession_number":"0002011420-26-000001","importance":30},{"ts":"2026-08-10","kind":"sec.insider.g","reporter":"SCULLY WILLIAM P","title":null,"shares":251553,"price_per_share":0,"usd_value":0,"security_title":"Ordinary Shares, par value $0.01 per share","importance":15},{"ts":"2026-08-06","kind":"sec.filing","form_type":"10-Q","title":"10-Q — PROTHENA CORP PUBLIC LTD CO — 2026-08-06","url_slug":"/sec/cik-0001559053/10-q/0001559053-26-000022","accession_number":"0001559053-26-000022","importance":45},{"ts":"2026-08-06","kind":"sec.filing","form_type":"8-K","title":"8-K — PROTHENA CORP PUBLIC LTD CO — 2026-08-06","url_slug":"/sec/cik-0001559053/8-k/0001559053-26-000021","accession_number":"0001559053-26-000021","importance":35},{"ts":"2026-08-06","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — PROTHENA CORP PUBLIC LTD CO — 2026-08-06","url_slug":"/sec/cik-0001559053/schedule-13g-a/0000315066-26-002104","accession_number":"0000315066-26-002104","importance":30},{"ts":"2026-07-30","kind":"sec.filing","form_type":"4","title":"4 — PROTHENA CORP PUBLIC LTD CO — 2026-07-30","url_slug":"/sec/cik-0001559053/4/0000905148-26-003409","accession_number":"0000905148-26-003409","importance":30},{"ts":"2026-07-30","kind":"sec.filing","form_type":"4","title":"4 — PROTHENA CORP PUBLIC LTD CO — 2026-07-30","url_slug":"/sec/cik-0001559053/4/0000905148-26-003410","accession_number":"0000905148-26-003410","importance":30},{"ts":"2026-07-30","kind":"sec.filing","form_type":"4","title":"4 — PROTHENA CORP PUBLIC LTD CO — 2026-07-30","url_slug":"/sec/cik-0001559053/4/0000905148-26-003412","accession_number":"0000905148-26-003412","importance":30},{"ts":"2026-07-30","kind":"sec.filing","form_type":"4","title":"4 — PROTHENA CORP PUBLIC LTD CO — 2026-07-30","url_slug":"/sec/cik-0001559053/4/0000905148-26-003414","accession_number":"0000905148-26-003414","importance":30},{"ts":"2026-07-30","kind":"sec.filing","form_type":"4","title":"4 — PROTHENA CORP PUBLIC LTD CO — 2026-07-30","url_slug":"/sec/cik-0001559053/4/0000905148-26-003415","accession_number":"0000905148-26-003415","importance":30},{"ts":"2026-07-30","kind":"sec.filing","form_type":"4","title":"4 — PROTHENA CORP PUBLIC LTD CO — 2026-07-30","url_slug":"/sec/cik-0001559053/4/0000905148-26-003416","accession_number":"0000905148-26-003416","importance":30},{"ts":"2026-07-30","kind":"sec.filing","form_type":"4","title":"4 — PROTHENA CORP PUBLIC LTD CO — 2026-07-30","url_slug":"/sec/cik-0001559053/4/0000905148-26-003417","accession_number":"0000905148-26-003417","importance":30},{"ts":"2026-07-29","kind":"sec.insider.s","reporter":"Isaacs Michael John","title":"General Counsel & Company Sec.","shares":8386,"price_per_share":8.4731,"usd_value":71055,"security_title":"Ordinary Shares, par value $0.01 per share","importance":35.0710554166},{"ts":"2026-07-29","kind":"sec.insider.s","reporter":"Kingston Anne Evans","title":"Chief Strategy Officer","shares":7662,"price_per_share":8.4729,"usd_value":64919,"security_title":"Ordinary Shares, par value $0.01 per share","importance":35.0649193598},{"ts":"2026-07-29","kind":"sec.filing","form_type":"144","title":"144 — PROTHENA CORP PUBLIC LTD CO — 2026-07-29","url_slug":"/sec/cik-0001559053/144/0001950047-26-007388","accession_number":"0001950047-26-007388","importance":30},{"ts":"2026-07-29","kind":"sec.filing","form_type":"144","title":"144 — PROTHENA CORP PUBLIC LTD CO — 2026-07-29","url_slug":"/sec/cik-0001559053/144/0001950047-26-007389","accession_number":"0001950047-26-007389","importance":30},{"ts":"2026-07-29","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — PROTHENA CORP PUBLIC LTD CO — 2026-07-29","url_slug":"/sec/cik-0001559053/schedule-13g-a/0002012383-26-002784","accession_number":"0002012383-26-002784","importance":30},{"ts":"2026-07-28","kind":"sec.insider.d","reporter":"Kinney Gene G.","title":"President and CEO","shares":84000,"price_per_share":8.56,"usd_value":719040,"security_title":"Ordinary Shares, par value $0.01 per share","importance":15.71904},{"ts":"2026-07-28","kind":"sec.insider.d","reporter":"Smith Brandon S.","title":"Chief Operating Officer","shares":78000,"price_per_share":8.56,"usd_value":667680,"security_title":"Ordinary Shares, par value $0.01 per share","importance":15.66768},{"ts":"2026-07-28","kind":"sec.insider.d","reporter":"Nguyen Tran","title":"Chief Strategy Officer and CFO","shares":57000,"price_per_share":8.56,"usd_value":487920,"security_title":"Ordinary Shares, par value $0.01 per share","importance":15.48792},{"ts":"2026-07-28","kind":"sec.insider.d","reporter":"Zago Wagner M.","title":"Chief Scientific Officer","shares":51000,"price_per_share":8.56,"usd_value":436560,"security_title":"Ordinary Shares, par value $0.01 per share","importance":15.43656},{"ts":"2026-07-28","kind":"sec.insider.d","reporter":"Swanson Chad J.","title":"Chief Development Officer","shares":40800,"price_per_share":8.56,"usd_value":349248,"security_title":"Ordinary Shares, par value $0.01 per share","importance":15.349248},{"ts":"2026-07-28","kind":"sec.insider.d","reporter":"Walker Karin L","title":"Chief Accounting Officer","shares":15000,"price_per_share":8.56,"usd_value":128400,"security_title":"Ordinary Shares, par value $0.01 per share","importance":15.1284},{"ts":"2026-07-28","kind":"sec.insider.f","reporter":"Isaacs Michael John","title":"General Counsel & Company Sec.","shares":4694,"price_per_share":8.56,"usd_value":40181,"security_title":"Ordinary Shares, par value $0.01 per share","importance":15.04018064},{"ts":"2026-07-28","kind":"sec.insider.f","reporter":"Kingston Anne Evans","title":"Chief Strategy Officer","shares":3498,"price_per_share":8.56,"usd_value":29943,"security_title":"Ordinary Shares, par value $0.01 per share","importance":15.02994288},{"ts":"2026-07-28","kind":"sec.insider.f","reporter":"Swanson Chad J.","title":"Chief Development Officer","shares":3467,"price_per_share":8.56,"usd_value":29678,"security_title":"Ordinary Shares, par value $0.01 per share","importance":15.02967752},{"ts":"2026-07-28","kind":"sec.insider.m","reporter":"Nguyen Tran","title":"Chief Strategy Officer and CFO","shares":57000,"price_per_share":null,"usd_value":0,"security_title":"Ordinary Shares, par value $0.01 per share","importance":15},{"ts":"2026-07-28","kind":"sec.insider.m","reporter":"Kinney Gene G.","title":"President and CEO","shares":84000,"price_per_share":null,"usd_value":0,"security_title":"Ordinary Shares, par value $0.01 per share","importance":15},{"ts":"2026-07-28","kind":"sec.insider.m","reporter":"Smith Brandon S.","title":"Chief Operating Officer","shares":78000,"price_per_share":null,"usd_value":0,"security_title":"Ordinary Shares, par value $0.01 per share","importance":15},{"ts":"2026-07-28","kind":"sec.insider.m","reporter":"Swanson Chad J.","title":"Chief Development Officer","shares":51000,"price_per_share":null,"usd_value":0,"security_title":"Ordinary Shares, par value $0.01 per share","importance":15},{"ts":"2026-07-28","kind":"sec.insider.m","reporter":"Walker Karin L","title":"Chief Accounting Officer","shares":15000,"price_per_share":null,"usd_value":0,"security_title":"Ordinary Shares, par value $0.01 per share","importance":15},{"ts":"2026-07-28","kind":"sec.insider.m","reporter":"Zago Wagner M.","title":"Chief Scientific Officer","shares":51000,"price_per_share":null,"usd_value":0,"security_title":"Ordinary Shares, par value $0.01 per share","importance":15},{"ts":"2026-06-16","kind":"sec.insider.p","reporter":"SCULLY WILLIAM P","title":null,"shares":20000,"price_per_share":7.8995,"usd_value":157990,"security_title":"Ordinary Shares, par value $0.01 per share","importance":50.15799},{"ts":"2026-06-15","kind":"sec.insider.g","reporter":"SCULLY WILLIAM P","title":null,"shares":325000,"price_per_share":0,"usd_value":0,"security_title":"Ordinary Shares, par value $0.01 per share","importance":15},{"ts":"2026-06-12","kind":"sec.filing","form_type":"3","title":"3 — PROTHENA CORP PUBLIC LTD CO — 2026-06-12","url_slug":"/sec/cik-0001559053/3/0000905148-26-002932","accession_number":"0000905148-26-002932","importance":30},{"ts":"2026-06-11","kind":"sec.insider.p","reporter":"SCULLY WILLIAM P","title":null,"shares":125000,"price_per_share":8.1698,"usd_value":1021225,"security_title":"Ordinary Shares, par value $0.01 per share","importance":51.021225},{"ts":"2026-06-09","kind":"sec.form144","reporter":"MALECEK MICHAEL J","title":"Previous Officer","shares":80000,"usd_value":740000,"security_title":"COMMON","approx_sale_date":"2026-06-09","accession_number":"0001193125-26-263019","importance":40.148},{"ts":"2026-06-09","kind":"sec.filing","form_type":"144","title":"144 — PROTHENA CORP PUBLIC LTD CO — 2026-06-09","url_slug":"/sec/cik-0001559053/144/0001193125-26-263019","accession_number":"0001193125-26-263019","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — SCULLY WILLIAM P — 2026-06-05","url_slug":"/sec/cik-0001045463/4/0001045463-26-000006","accession_number":"0001045463-26-000006","importance":30},{"ts":"2026-06-04","kind":"sec.insider.p","reporter":"SCULLY WILLIAM P","title":null,"shares":50000,"price_per_share":9.3059,"usd_value":465295,"security_title":"Ordinary Shares, par value $0.01 per share","importance":50.465295},{"ts":"2026-06-02","kind":"sec.insider.p","reporter":"SCULLY WILLIAM P","title":null,"shares":50000,"price_per_share":9.426,"usd_value":471300,"security_title":"Ordinary Shares, par value $0.01 per share","importance":50.4713},{"ts":"2026-05-15","kind":"sec.filing","form_type":"8-K","title":"8-K — PROTHENA CORP PUBLIC LTD CO — 2026-05-15","url_slug":"/sec/cik-0001559053/8-k/0001193125-26-226968","accession_number":"0001193125-26-226968","importance":35},{"ts":"2026-05-15","kind":"sec.filing","form_type":"4","title":"4 — PROTHENA CORP PUBLIC LTD CO — 2026-05-15","url_slug":"/sec/cik-0001559053/4/0000905148-26-002468","accession_number":"0000905148-26-002468","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"4","title":"4 — PROTHENA CORP PUBLIC LTD CO — 2026-05-15","url_slug":"/sec/cik-0001559053/4/0000905148-26-002470","accession_number":"0000905148-26-002470","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — PROTHENA CORP PUBLIC LTD CO — 2026-05-15","url_slug":"/sec/cik-0001559053/schedule-13g-a/0001104659-26-062524","accession_number":"0001104659-26-062524","importance":30},{"ts":"2026-05-11","kind":"sec.13dg","reporter":"SCULLY WILLIAM P","shares":5378846,"percent_of_class":10.3,"security_title":"SCHEDULE 13G/A","accession_number":"0001045463-26-000002","excerpt":null,"importance":55}]}